Hemispherx Biopharma (HEB)

0.202 -0.00  -1.99%  May 21, 2:26PM
Add to Watchlists Create an Alert

Hemispherx Biopharma R&D Expense Quarterly:

3.75M for Dec. 31, 2012
View Full Chart

Hemispherx Biopharma R&D Expense Quarterly Chart

    Hemispherx Biopharma Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 3.75M
    Sept. 30, 2012 2.357M
    June 30, 2012 1.736M
    March 31, 2012 1.665M
    Dec. 31, 2011 1.708M
    Sept. 30, 2011 1.75M
    June 30, 2011 1.624M
    March 31, 2011 1.64M
    Dec. 31, 2010 2.115M
    Sept. 30, 2010 1.808M
    June 30, 2010 1.694M
    March 31, 2010 1.996M
    Dec. 31, 2009 2.245M
    Sept. 30, 2009 1.173M
    June 30, 2009 1.982M
    March 31, 2009 1.595M
    Dec. 31, 2008 1.739M
    Sept. 30, 2008 1.594M
    June 30, 2008 1.16M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    HEB R&D Expense Quarterly Benchmarks

    Companies
    Novavax 9.412M
    Sinovac Biotech 1.251M
    Biocryst Pharmaceuticals 7.411M

    HEB R&D Expense Quarterly Rankings

    Overall 88th percentile
    920 of 8002
    Sector 61st percentile
    266 of 684 in Healthcare
    Industry 50th percentile
    122 of 248 in Biotechnology

    HEB R&D Expense Quarterly Range, Past 5 Years

    Minimum 1.160M Jun 2008
    Maximum 3.75M Dec 2012
    Average 1.860M